Sabrina Schrauf

Title: Sabrina Schrauf: Innovator in Vaccine Development

Introduction

Sabrina Schrauf is a prominent inventor based in Mörbisch am See, Austria. She has made significant contributions to the field of vaccine development, particularly in relation to Zika virus and other infectious agents. With a total of 2 patents, her work is paving the way for innovative solutions in immunology.

Latest Patents

Sabrina Schrauf's latest patents include groundbreaking inventions in the realm of recombinant Zika vaccines. The first patent focuses on immunogenic or vaccine compositions that comprise at least one recombinant Zika virus antigen. This invention is crucial for developing effective vaccines against Zika virus diseases. The second patent presents chromatography-based purification strategies for large and pleomorphic infectious virus particles. This method aims to yield virus preparations with significantly reduced levels of contaminating host cell DNA, enhancing the safety and efficacy of vaccine compositions.

Career Highlights

Sabrina Schrauf is currently associated with Themis Bioscience GmbH, where she continues to advance her research in vaccine technology. Her innovative approaches have garnered attention in the scientific community, contributing to the development of safer and more effective vaccines.

Collaborations

Sabrina collaborates with esteemed colleagues such as Matthias Müllner and Erich Tauber. Their combined expertise fosters a dynamic research environment that enhances the potential for groundbreaking discoveries in vaccine development.

Conclusion

Sabrina Schrauf's contributions to vaccine innovation are noteworthy and impactful. Her patents reflect a commitment to improving public health through advanced immunological research. The future of vaccine development looks promising with inventors like her leading the way.